Fraud concerns raise red flags for India’s booming tiny IPOs

A string of accounting frauds unearthed by India’s securities regulator this month poses another risk to the blistering rally in shares of tiny businesses.

A string of accounting frauds unearthed by India’s securities regulator this month poses another risk to the blistering rally in shares of tiny businesses.

Varanium Cloud Ltd. and Add-Shop E-Retail Ltd. — both listed on the small and medium enterprises platform —  were found to have manipulated their financial statements to fuel gains in their shares, according to initial orders issued by the Securities and Exchange Board of India. The authorities have banned both companies and their founders from dealing in the country’s capital market.

The crackdown comes after the regulator issued warnings earlier this year of price manipulation in tiny IPOs. Analysts say the development presages greater regulatory action, which may temper further gains in the S&P BSE SME IPO Index of micro listings that has soared more than 5,000 per cent since the start of 2021. 

Also read: SEBI bans SME firm from capital market for misusing IPO proceeds“This is just the tip of the iceberg,” said Ambareesh Baliga, an independent market expert who has been tracking Indian equities for over two decades. “Fewer regulations were meant to attract good quality SMEs to the market, instead it has attracted the wrong ones.” 

Technology firm Varanium Cloud was found to have misused funds raised from its public offering in 2022, and “manipulated its financial statements by recording fictitious sales and purchases,” SEBI said in its order dated May 10.

Add-Shop E-Retail has been “passing fictitious sales transactions between its related parties” to inflate sales, the regulator said in a separate notice dated May 6. 

In both cases, the founders had reduced their stakes in the companies during the period under investigation, according to SEBI. 

The findings underscore the vulnerability of millions of traders to the risks of price manipulation in this segment due to fewer compliance requirements. They also highlight the limitation of regulatory warnings aimed at curbing enthusiasm for tiny IPOs in India, where retail investors have emerged as a major force.

Earlier this year, regulators clamped down on equity markets financing to cool pre-IPO sale frenzy. Still, the nation’s market for first-time share sales remains vibrant, with 102 deals priced since the start of 2024. That’s nearly three times as many as in China, data compiled by Bloomberg show. The BSE SME IPO Index surged to a record last week. 

“Another 10 cases like this and this bubble will burst,” Baliga said. The veteran investor and investment advisor warned that majority of the investors are putting their money in such small public offerings with their eyes closed.

More stories like this are available on bloomberg.com

Like (0)
Previous May 14, 2024 4:16 pm
Next May 14, 2024 4:16 pm

Related posts

  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • Zuckerberg: There will no longer be a shortage of AI chips, but there will be a bottleneck in power supply

    Sina Technology News Beijing time on the afternoon of May 13th, Meta co-founder and CEO Mark Zuckerberg recently said in an exclusive interview with Youtube podcast author Dwarkesh Patel that the AI ​​chip shortage that has plagued the industry for a long time has basically ended, but Energy supply issues will become the next major bottleneck

    US stock market May 13, 2024
  • Holding companies outpace Nifty, Sensex in returns: Way2Wealth report

    Holding companies index outperformed the benchmark index over a longer investment horizon, according to a report by brokerage firm Way2Wealth. Returns of the eight holding companies covered by the study were at 95 per cent, 26 per cent and 27 per cent over a one-year return, five-year CAGR, and 10-year CAGR, respectively. This outpaced the returns of Nifty 50 index and Sensex at 27/23 per cent, 14 per cent and 13 per cent during the respective period.

    US stock market April 24, 2024
  • SoftBank’s sales in fiscal year 2023 are 6.76 trillion yen, net profit is 209.2 billion yen

    SoftBank today released its financial report for fiscal year 2023 ending March 31, 2024: net sales were 6.76 trillion yen, a year-on-year increase of 2.8%

    US stock market May 13, 2024
  • Novavax gains about 3.5% pre-market after hedge fund investors recommend two new director candidates

    Glonghui, April 15 | US hedge fund Shah Capital has recommended that Covid-19 vaccine maker Novavax appoint two new independent directors, Suresh Katta and Venkat Peri, to its board. Shah Capital, which owns about 6.7% of Novavax’s outstanding common stock, said the low share price reflected the board and management’s failure to capitalize on many important competitive advantages and seize opportunities in the overall market. “We welcome the views of our shareholders and value their input on our strategy,” Novavax said in a statement. Novavax is one of the most shorted stocks on the Nasdaq (16175.0941, 0.00, 0.00%) and is currently trading near all-time lows. As of last trading day’s close, the stock had fallen more than 53% in the past 12 months. The stock rose about 3.5% premarket.

    US stock market April 15, 2024
  • Guangxin Shares (603599.SH): Net profit in the first quarter was 225 million yuan, a year-on-year decrease of 56.80%

    Gelonghui April 25 | Guangxin Co., Ltd. (603599.SH) released its first quarter report for 2024. During the reporting period, the company’s operating income was 1.215 billion yuan, a year-on-year decrease of 36.89%; the net profit attributable to shareholders of the listed company was 225 million yuan, A year-on-year decrease of 56.80%; the net profit attributable to shareholders of listed companies excluding non-recurring gains and losses was 215 million yuan, a year-on-year decrease of 55.06%; basic earnings per share was 0.25 yuan/share.

    US stock market April 25, 2024